Immuneering Corporation IMRX Q1 2025 earnings
Reported May 5, 2025 · Before market open
EPS estimate-$0.41
Next report
Aug 12, 2026 (in a month)EPS estimate-$0.26
Versus estimates
Diluted EPS
Ask the moment Immuneering Corporation reports.
Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.
Connect your AI
Claude
Questions, answered.
- When did Immuneering Corporation report Q1 2025 earnings?
- Immuneering Corporation (IMRX) reported Q1 2025 earnings on May 5, 2025 before market open.
- What were Immuneering Corporation's Q1 2025 revenue and EPS?
- Immuneering Corporation reported diluted EPS of $-0.42 for Q1 2025.
- Did Immuneering Corporation beat estimates in Q1 2025?
- EPS missed the consensus estimate of $-0.41 by $0.01.
- How did Immuneering Corporation's Q1 2025 results compare year-over-year?
- Compared to the same quarter a year prior, diluted EPS grew 14.3% from $-0.49.
- Where can I find Immuneering Corporation's Q1 2025 SEC filings?
- You can read the 10-Q periodic report (0001790340-25-000061) directly on SEC EDGAR. The filing index links above go to sec.gov.